Retrieved from https://studentshare.org/family-consumer-science/1417716-in-adult-ventilated-patients-what-are-the-effects
https://studentshare.org/family-consumer-science/1417716-in-adult-ventilated-patients-what-are-the-effects.
Ventilator-associated pneumonia can result in enormous clinical complications, increased length of hospital stay, and a substantial financial impact on this very complicated and critically ill population. Respiratory tract infections from aspiration are seen as the most common types of resistant hospital-related lung infections in the intensive care unit (ICU) patient population. This highly vulnerable population of patients is at high risk for aspiration and therefore at high risk for the complications brought about by VAP, the worst of which is death.
The incidence rate of VAP is 5 to 10 cases per 1.000 hospital admissions with an estimated 250,00 to 200,00 cases occurring per years in the United States alone (Koenig, 2006)Length of stay due to complications from intubation can vary from days to months, depending on what other medical and pulmonary complications already exist. VAP increases the length of stay (LOS) from 4 to 13 days(Koenig, 2006) VAPs are reported to cause a huge financial burden on institutions (Safdar, 2005) with associated costs being as high as $40,000 with each diagnosis of ventilator-associated pneumonia, however, estimates can be much higher (Craven,2006).
Craven (2006) reports that ventilator-associated pneumonia can have a major determination on the patient’s morbidity. Such an infection can “double the rate of mortality”(Safdar, 2005). The mortality attributable to VAP has been reported to range between 1 and 5 percent (Craven, 2005; Hurley, 2008; Panchabhai, et al. 2009; Munro, 2009). Aspiration of gastric secretions in combination with bacterial growth in the oral cavity has been widely documented as the predominant causative agents for VAP (Prescott, 2010), Craven, 2006).
Evidence-based research with Chlorhexidine oral rinse has been studied and documented to be beneficial in the reduction of hospital-acquired infection in the respiratory tract of the intensive care population (Prescott, 2010, Panchabhai, 2009, Halm, 2009, Craven, 2011). The use of
...Download file to see next pages Read More